Non-steroidal Anti-Inflammatory Drugs Market Size, Trends, Analysis, and Outlook By Disease (Arthritis, Migraine, Ophthalmic Diseases, Others), By Route of Administration (Oral, Topical, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
The global Non-steroidal Anti-Inflammatory Drugs market size is poised to register 5.97% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Non-steroidal Anti-Inflammatory Drugs market across By Disease (Arthritis, Migraine, Ophthalmic Diseases, Others), By Route of Administration (Oral, Topical, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy).
The Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market is witnessing steady growth attributed to the widespread prevalence of inflammatory conditions, the rising geriatric population, and the increasing demand for over-the-counter pain relief medications. NSAIDs are a class of medications used to alleviate pain, reduce inflammation, and lower fever by inhibiting the production of prostaglandins. Key drivers of market growth include the growing incidence of arthritis, musculoskeletal disorders, and other inflammatory conditions, as well as the expanding applications of NSAIDs in the management of acute and chronic pain. Additionally, the availability of various NSAID formulations including oral tablets, capsules, topical creams, and gels is driving market expansion. Moreover, the introduction of novel NSAID formulations with improved safety profiles, reduced gastrointestinal side effects, and enhanced efficacy is fueling innovation in the market. Furthermore, the increasing adoption of NSAIDs for the treatment of headache, menstrual pain, dental pain, and minor injuries, coupled with the expanding product portfolios of pharmaceutical companies, is driving market growth in the foreseeable future.
Non-steroidal Anti-Inflammatory Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Non-steroidal Anti-Inflammatory Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Non-steroidal Anti-Inflammatory Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Non-steroidal Anti-Inflammatory Drugs industry.
Key market trends defining the global Non-steroidal Anti-Inflammatory Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Non-steroidal Anti-Inflammatory Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Non-steroidal Anti-Inflammatory Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Non-steroidal Anti-Inflammatory Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Non-steroidal Anti-Inflammatory Drugs industry
Leading Non-steroidal Anti-Inflammatory Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Non-steroidal Anti-Inflammatory Drugs companies.
Non-steroidal Anti-Inflammatory Drugs Market Study- Strategic Analysis Review
The Non-steroidal Anti-Inflammatory Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Non-steroidal Anti-Inflammatory Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Non-steroidal Anti-Inflammatory Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Non-steroidal Anti-Inflammatory Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Non-steroidal Anti-Inflammatory Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Non-steroidal Anti-Inflammatory Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Non-steroidal Anti-Inflammatory Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Non-steroidal Anti-Inflammatory Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Non-steroidal Anti-Inflammatory Drugs in Asia Pacific. In particular, China, India, and South East Asian Non-steroidal Anti-Inflammatory Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Non-steroidal Anti-Inflammatory Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Non-steroidal Anti-Inflammatory Drugs.
Non-steroidal Anti-Inflammatory Drugs Market Company Profiles
The global Non-steroidal Anti-Inflammatory Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer AG, Dr. Reddy’s Laboratories Ltd, GSK plc, Johnson And Johnson Services Inc, Merck & Co. Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Viatris Inc
Recent Non-steroidal Anti-Inflammatory Drugs Market Developments
The global Non-steroidal Anti-Inflammatory Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Non-steroidal Anti-Inflammatory Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration
Oral
Topical
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographical Segmentation:
Bayer AG
Dr. Reddy’s Laboratories Ltd
GSK plc
Johnson And Johnson Services Inc
Merck & Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
The Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market is witnessing steady growth attributed to the widespread prevalence of inflammatory conditions, the rising geriatric population, and the increasing demand for over-the-counter pain relief medications. NSAIDs are a class of medications used to alleviate pain, reduce inflammation, and lower fever by inhibiting the production of prostaglandins. Key drivers of market growth include the growing incidence of arthritis, musculoskeletal disorders, and other inflammatory conditions, as well as the expanding applications of NSAIDs in the management of acute and chronic pain. Additionally, the availability of various NSAID formulations including oral tablets, capsules, topical creams, and gels is driving market expansion. Moreover, the introduction of novel NSAID formulations with improved safety profiles, reduced gastrointestinal side effects, and enhanced efficacy is fueling innovation in the market. Furthermore, the increasing adoption of NSAIDs for the treatment of headache, menstrual pain, dental pain, and minor injuries, coupled with the expanding product portfolios of pharmaceutical companies, is driving market growth in the foreseeable future.
Non-steroidal Anti-Inflammatory Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Non-steroidal Anti-Inflammatory Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Non-steroidal Anti-Inflammatory Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Non-steroidal Anti-Inflammatory Drugs industry.
Key market trends defining the global Non-steroidal Anti-Inflammatory Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Non-steroidal Anti-Inflammatory Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Non-steroidal Anti-Inflammatory Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Non-steroidal Anti-Inflammatory Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Non-steroidal Anti-Inflammatory Drugs industry
Leading Non-steroidal Anti-Inflammatory Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Non-steroidal Anti-Inflammatory Drugs companies.
Non-steroidal Anti-Inflammatory Drugs Market Study- Strategic Analysis Review
The Non-steroidal Anti-Inflammatory Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Non-steroidal Anti-Inflammatory Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Non-steroidal Anti-Inflammatory Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Non-steroidal Anti-Inflammatory Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Non-steroidal Anti-Inflammatory Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Non-steroidal Anti-Inflammatory Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Non-steroidal Anti-Inflammatory Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Non-steroidal Anti-Inflammatory Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Non-steroidal Anti-Inflammatory Drugs in Asia Pacific. In particular, China, India, and South East Asian Non-steroidal Anti-Inflammatory Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Non-steroidal Anti-Inflammatory Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Non-steroidal Anti-Inflammatory Drugs.
Non-steroidal Anti-Inflammatory Drugs Market Company Profiles
The global Non-steroidal Anti-Inflammatory Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer AG, Dr. Reddy’s Laboratories Ltd, GSK plc, Johnson And Johnson Services Inc, Merck & Co. Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Viatris Inc
Recent Non-steroidal Anti-Inflammatory Drugs Market Developments
The global Non-steroidal Anti-Inflammatory Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Non-steroidal Anti-Inflammatory Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration
Oral
Topical
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Bayer AG
Dr. Reddy’s Laboratories Ltd
GSK plc
Johnson And Johnson Services Inc
Merck & Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Non-steroidal Anti-Inflammatory Drugs Market Overview and Key Findings, 2024
1.2 Non-steroidal Anti-Inflammatory Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Non-steroidal Anti-Inflammatory Drugs Market Growth Opportunities to 2030
1.4 Key Non-steroidal Anti-Inflammatory Drugs Market Trends and Challenges
1.4.1 Non-steroidal Anti-Inflammatory Drugs Market Drivers and Trends
1.4.2 Non-steroidal Anti-Inflammatory Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Non-steroidal Anti-Inflammatory Drugs Companies
2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Non-steroidal Anti-Inflammatory Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Non-steroidal Anti-Inflammatory Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration
Oral
Topical
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.2 Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.5 Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.8 North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.11 South America Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.14 Middle East Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Non-steroidal Anti-Inflammatory Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
7. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS COMPANY PROFILES
8.1 Profiles of Leading Non-steroidal Anti-Inflammatory Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer AG
Dr. Reddy’s Laboratories Ltd
GSK plc
Johnson And Johnson Services Inc
Merck & Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Non-steroidal Anti-Inflammatory Drugs Market Overview and Key Findings, 2024
1.2 Non-steroidal Anti-Inflammatory Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Non-steroidal Anti-Inflammatory Drugs Market Growth Opportunities to 2030
1.4 Key Non-steroidal Anti-Inflammatory Drugs Market Trends and Challenges
1.4.1 Non-steroidal Anti-Inflammatory Drugs Market Drivers and Trends
1.4.2 Non-steroidal Anti-Inflammatory Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Non-steroidal Anti-Inflammatory Drugs Companies
2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Non-steroidal Anti-Inflammatory Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Non-steroidal Anti-Inflammatory Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration
Oral
Topical
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.2 Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.5 Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.8 North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.11 South America Pacific Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Non-steroidal Anti-Inflammatory Drugs Market, 2025
5.14 Middle East Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Non-steroidal Anti-Inflammatory Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Non-steroidal Anti-Inflammatory Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Non-steroidal Anti-Inflammatory Drugs Industry Drivers and Opportunities
7. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS COMPANY PROFILES
8.1 Profiles of Leading Non-steroidal Anti-Inflammatory Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer AG
Dr. Reddy’s Laboratories Ltd
GSK plc
Johnson And Johnson Services Inc
Merck & Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
